Several biomarkers (i.e. CRP, IP-10, TARC, ICAM-1, and VCAM-1) were found to be elevated in the CSF of MCI patients but not in AD, suggesting microglia activation at an early predementia stage. This evidence concerns the gene CXCL10 and Alzheimer disease.